| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88239945 | FILING DATE | 12/21/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MAYES, LAURIE ANN |
L.O. ASSIGNED | 101 |
PUB INFORMATION |
|||
| RUN DATE | 01/08/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 647-EXAMINERS AMENDMENT - MAILED | ||
| STATUS DATE | 01/07/2020 | ||
| LITERAL MARK ELEMENT | NEXTSEQ | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | YES | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | NEXTSEQ |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Illumina Inc. |
| ADDRESS | 5200 Illumina Way San Diego, CA 92122 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Reagents, assays, enzymes, chemical preparations all for scientific and research use; biological specimens in the nature of human tissue or human body fluid, animal tissue or animal body fluid for scientific and research use; cultures of microorganisms, plant tissue and nucleotides for scientific and research use, not for medical or veterinary purposes; reagents kits comprised primarily of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and also comprised of enzymes for scientific and research use, not for medical or veterinary purposes; nucleotides for medical research; chemical buffer solutions used in analytical chemistry |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Reagents for medical and veterinary use, clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing genetic material; enzymes for medical and veterinary use, nucleotides for medical and veterinary use, buffers for medical and veterinary diagnostic use for testing genetic material, chemical reagents for medical and veterinary use, and biological preparations in the nature of human tissue cultures for medical and veterinary use, human body fluids for medical and veterinary use, animal tissue cultures for medical and veterinary use, and animal body fluids for medical and veterinary use, cultures of microorganisms for medical or veterinary use, and plant tissue for medical and veterinary use in the fields of medical diagnostics, veterinary diagnostics, clinical and diagnostic laboratory medicine, veterinary medicine, and genetics |
| INTERNATIONAL CLASS | 009 |
| DESCRIPTION TEXT | Computer hardware and computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Clinical and medical diagnostic instruments, namely, nucleic acid sequencers; scientific apparatus and instruments, namely, nucleic acid sequencers for use in medical and veterinary diagnosis and in medical and veterinary treatment |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | 01/15/2014 | FIRST USE IN COMMERCE DATE | 01/15/2014 | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 01/15/2014 | FIRST USE IN COMMERCE DATE | 01/15/2014 | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 009 | FIRST USE DATE | 01/15/2014 | FIRST USE IN COMMERCE DATE | 01/15/2014 | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | 01/15/2014 | FIRST USE IN COMMERCE DATE | 01/15/2014 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 01/07/2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 019 |
| 01/07/2020 | ALIE | A | ASSIGNED TO LIE | 018 |
| 01/07/2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 017 |
| 01/07/2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 016 |
| 01/07/2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 015 |
| 08/21/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 014 |
| 08/21/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 013 |
| 07/11/2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 012 |
| 07/11/2019 | GNFR | O | FINAL REFUSAL E-MAILED | 011 |
| 07/11/2019 | CNFR | R | FINAL REFUSAL WRITTEN | 010 |
| 06/26/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 06/25/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 06/25/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 03/18/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 03/18/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 03/18/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 03/16/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 01/15/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 12/25/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Susan M. Natland |
| CORRESPONDENCE ADDRESS | Susan M. Natland Knobbe, Martens, Olson & Bear, LLP 2040 Main Street, 14th Floor Irvine CA 92614 |
| DOMESTIC REPRESENTATIVE | NONE |